Patent Application
Provisional
Small
App. No. 62/822,290
· Confirmation No. 9904
ANTI-EGF ANTIBODIES GENERATED BY VACCINATION SIGNIFICANTLY IMPROVE THE ACTIVITY OF KINASE INHIBITORS IN PRECLINICAL MODELS
Applicant:
In3Bio Ltd.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-02-04 | OATH |
Oath or Declaration filed | 42 | View | |
| 2026-02-04 | OATH |
Oath or Declaration filed | 42 | View | |
| 2019-12-05 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2019-12-05 | PD.AUTH.G |
Acceptance of Permission to Access Application | 1 | View | |
| 2019-12-03 | PD.TO.AUTH |
Authorization or Rescission of Authorization to Access Application by Digital Access Service /Priority Document Exchange Office | 2 | View | |
| 2019-12-03 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-05-14 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2019-03-22 | ADS |
Application Data Sheet | 7 | View | |
| 2019-03-22 | SPEC |
Specification | 1 | View | |
| 2019-03-22 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-03-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View |
Inventors
Erik D'Hondt
Bazel, BELGIUM
Miguel Ángel Molina-Vila
Badalona, SPAIN
Attorneys & Agents of Record
Prosecution
- Customer No.
- 26486
- Docket No.
- 48199-105 PROV V
- Confirmation No.
- 9904
Child
Claims priority from a provisional application
→
App. 16/534,230
· US 12,257,245
Filed 2019-08-07
· Patented Case
Child
Claims priority from a provisional application
→
App. 19/053,628
Filed 2025-02-14
· Abandoned -- Incomplete Application (Pre-examination)
Child
PCT
Claims priority from a provisional application
→
PCT/US2019/045421
· International Application Withdrawn
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/822,290
- Filed
- 2019-03-22
External Links